secwatch.observer — SEC 8-K summary
======================================

Issuer:     ORAMED PHARMACEUTICALS INC. (ORMP)
CIK:        0001176309
Form:       8-K
Filed at:   2022-12-12T23:59:59+00:00
Accession:  0001213900-22-078902
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Oramed posts investor presentation; no new material financial or operational data disclosed
--------------------------------------------------------------------------------

- Filed an investor presentation dated December 12, 2022 on its website.
- Presentation titled 'Addressing the Multibillion-Dollar Injectable Drug Markets with Oral Formulations' provides a general overview.
- No specific financial updates, guidance changes, or pipeline milestones were included in the filing.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1176309/000121390022078902/0001213900-22-078902-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1176309/000121390022078902/ea169983-8k_oramed.htm
  HTML page:      https://secwatch.observer/filing/0001213900-22-078902

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer